Neurocrine Biosciences In... (NBIX)
NASDAQ: NBIX
· Real-Time Price · USD
132.85
1.54 (1.17%)
At close: Aug 15, 2025, 3:59 PM
132.90
0.04%
After-hours: Aug 15, 2025, 04:34 PM EDT
Neurocrine Biosciences Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 264M | 194.1M | 233M | 349.1M | 139.7M | 396.3M | 251.1M | 293.7M | 160.2M | -90.4M | 262.9M | 212.2M | 163.3M | 270.2M | 340.8M | 311.1M | 368M | 352.6M |
Short-Term Investments | 711.6M | 749.4M | 843.1M | 878.9M | 899.2M | 814.3M | 780.5M | 801.4M | 816.5M | 1.14B | 726.4M | 587.2M | 485M | 394.7M | 370.5M | 454.8M | 516.9M | 521.1M |
Long-Term Investments | 961.3M | 94.2M | 864.3M | 770.6M | 789.4M | 871.9M | 849.4M | 587.5M | 515.6M | 380.3M | 401.5M | 457.5M | 489M | 632.3M | 624.4M | 549M | 376.7M | 288.5M |
Other Long-Term Assets | 21.6M | 830.6M | 15.5M | 61.6M | 49.8M | 42.9M | 49.6M | 43.1M | 35.9M | 24.9M | 25M | 10.5M | 10M | 10.1M | 4.4M | 3.2M | 3.2M | 4.6M |
Receivables | 595.7M | 516M | 479.1M | 481.1M | 468.2M | 450.7M | 439.3M | 417.8M | 387.6M | 391.6M | 350M | 301.2M | 279M | 263.5M | 185.5M | 163.8M | 158.5M | 147.8M |
Inventory | 56.9M | 59.1M | 57.4M | 45.8M | 42.5M | 37.2M | 38.3M | 28.8M | 31.7M | 33.4M | 35.1M | 37M | 29.3M | 29M | 30.5M | 25.5M | 28.3M | 30.1M |
Other Current Assets | 120.7M | 119.3M | 112.1M | 121.7M | 120.2M | 100.5M | 97.8M | 108.2M | 100.6M | 113.2M | 79.1M | 67.9M | 62.7M | 60.8M | 45.5M | 50.5M | 38.4M | 33.8M |
Total Current Assets | 1.75B | 1.64B | 1.72B | 1.88B | 1.67B | 1.8B | 1.61B | 1.65B | 1.5B | 1.43B | 1.45B | 1.21B | 1.02B | 1.02B | 972.8M | 1.01B | 1.11B | 1.09B |
Property-Plant & Equipment | 584M | 589.2M | 592M | 337.3M | 343M | 346.1M | 347.3M | 149.6M | 149.1M | 147.2M | 145.6M | 150.5M | 159M | 158.6M | 155.8M | 149M | 150.3M | 142.3M |
Goodwill & Intangibles | 37.2M | 36.4M | 36.5M | 34.5M | 33.5M | 34.3M | 35.5M | 34.9M | 36.9M | 37.2M | 37.2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 2.14B | 2.05B | 1.99B | 1.66B | 1.64B | 1.67B | 1.64B | 1.2B | 1.12B | 927M | 915.2M | 937.9M | 986.4M | 1.13B | 1.1B | 1.01B | 846.3M | 761M |
Total Assets | 3.89B | 3.69B | 3.72B | 3.54B | 3.31B | 3.47B | 3.25B | 2.85B | 2.61B | 2.36B | 2.37B | 2.14B | 2.01B | 2.14B | 2.07B | 2.02B | 1.96B | 1.85B |
Account Payables | 104.6M | 110M | 110M | 95.7M | 107.2M | 87.3M | 108.9M | 93.8M | 391.6M | 355.7M | 67.3M | 297.8M | 265.7M | n/a | 51.5M | n/a | n/a | n/a |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | 24.8M | 339.9M | -93.8M | -391.6M | -374.1M | n/a | -297.8M | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | 122.8M | 170.1M | 169.9M | 169.7M | n/a | 169.4M | 169.2M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 317M | 522.9M | 297.7M | 256.9M | 4.6M | 137.9M | 257.6M | 73.6M | 3.5M | 18.4M | 29.7M | 800K | 2.9M | 253.5M | 82.7M | 225.9M | 212.9M | 190M |
Total Current Liabilities | 546.3M | 522.9M | 507.7M | 429.7M | 398.5M | 712.9M | 654.8M | 691.6M | 582.5M | 374.1M | 537.7M | 485.1M | 285.7M | 253.5M | 245.8M | 225.9M | 212.9M | 190M |
Long-Term Debt | n/a | 447.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 169.5M | n/a | n/a | 169M | 377.7M | 335.1M | 330.7M | 326.3M | 322M |
Other Long-Term Liabilities | 210.1M | 181.6M | 294.5M | 135M | 141.1M | 120.5M | 106.3M | 68.6M | 88.5M | 41.3M | 29.7M | 17.1M | 28M | 19.7M | 12.3M | 8.3M | 29M | 21.3M |
Total Long-Term Liabilities | 649.2M | 629.1M | 749.6M | 386.4M | 397.3M | 373.4M | 364.6M | 154.5M | 177.6M | 301.2M | 123.2M | 113.7M | 296.6M | 499.9M | 452.7M | 445.4M | 464.3M | 450.8M |
Total Liabilities | 1.2B | 1.15B | 1.13B | 816.1M | 795.8M | 1.09B | 1.02B | 846.1M | 760.1M | 675.3M | 660.9M | 598.8M | 582.3M | 753.4M | 698.5M | 671.3M | 677.2M | 640.8M |
Total Debt | 439.1M | 447.5M | 455.1M | 251.4M | 291.6M | 546.9M | 428.4M | 255.8M | 258.8M | 259.9M | 262.9M | 265.8M | 268.6M | 480.2M | 440.4M | 437.1M | 435.3M | 429.5M |
Common Stock | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K |
Retained Earnings | 84.5M | -5.3M | 29.2M | 81.1M | -48.7M | -113.7M | -157.1M | -304.8M | -387.9M | -483.4M | -406.8M | -495.8M | -564.3M | -547.4M | -635.8M | -628.5M | -651M | -693.3M |
Comprehensive Income | 12.5M | 9M | 5.8M | 14.5M | 2.5M | 3.3M | 7M | -1.7M | -1.1M | -2.7M | -7.9M | -14M | -12.2M | -9.3M | -1.7M | 400K | 700K | 1M |
Shareholders Equity | 2.69B | 2.54B | 2.59B | 2.72B | 2.51B | 2.39B | 2.23B | 2B | 1.85B | 1.68B | 1.71B | 1.54B | 1.42B | 1.39B | 1.37B | 1.35B | 1.28B | 1.21B |
Total Investments | 1.67B | 843.6M | 1.71B | 1.65B | 1.69B | 1.69B | 1.63B | 934.2M | 989.5M | 1.14B | 1.13B | 1.04B | 974M | 1.03B | 994.9M | 1B | 893.6M | 809.6M |